Best Donor Choice: It’s in the Eye of the Beholder!

By Basem M. William, MD One of the major leaps in hematopoietic stem cell transplantation (HSCT) is the increasingly successful use of alternative donors, thereby allowing the delivery of a potentially curative transplant to approximately 75 percent of patients who do...

A Quantum Leap in Myeloma Therapy

By Binod Dhakal, MD, MS More than a century ago, the brilliant physicist Max Planck investigated an obscure subject and sparked a revolution in physics. A profoundly conservative thinker, Planck had to disavow some orthodox theoretical ideas to assume that the total...

Lymphoma Roundup: Verdict on This Year’s Annual Meeting

By Basem M. William, MD Since Thomas Hodgkin’s initial characterization of lymphomas in 1832 and the first administration of mustard to a patient with lymphoma 100 years later amid the secrecy of a World War II gas program, much has changed. Multiple recurrent themes...